BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33230924)

  • 1. The impact of pre-eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy - analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study).
    Magee LA; Singer J; Lee T; Rey E; Asztalos E; Hutton E; Helewa M; Logan AG; Ganzevoort W; Welch R; Thornton JG; Woo Kinshella ML; Green M; Tsigas E; von Dadelszen P;
    BJOG; 2021 Jul; 128(8):1373-1382. PubMed ID: 33230924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S; Medley N; Williams MJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
    Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a definition of pre-eclampsia.
    North RA; Taylor RS; Schellenberg JC
    Br J Obstet Gynaecol; 1999 Aug; 106(8):767-73. PubMed ID: 10453825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?
    Magee LA; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort W; Welch R; Thornton JG; Moutquin JM;
    Hypertension; 2016 Nov; 68(5):1153-1159. PubMed ID: 27620393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial).
    Beardmore-Gray A; Vousden N; Charantimath U; Katageri G; Bellad M; Kapembwa K; Chinkoyo S; Vwalika B; Clark M; Hunter R; Seed P; Goudar S; Chappell LC; Shennan A
    Trials; 2020 Nov; 21(1):960. PubMed ID: 33228794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and fetal outcome in women with hypertensive disorders of pregnancy: the impact of prenatal care.
    Barbosa IR; Silva WB; Cerqueira GS; Novo NF; Almeida FA; Novo JL
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):140-6. PubMed ID: 26220808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
    Reddy M; Fenn S; Rolnik DL; Mol BW; da Silva Costa F; Wallace EM; Palmer KR
    Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
    Rotchell YE; Cruickshank JK; Gay MP; Griffiths J; Stewart A; Farrell B; Ayers S; Hennis A; Grant A; Duley L; Collins R
    Br J Obstet Gynaecol; 1998 Mar; 105(3):286-92. PubMed ID: 9532988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm and term pre-eclampsia: Relative burdens of maternal and perinatal complications.
    von Dadelszen P; Syngelaki A; Akolekar R; Magee LA; Nicolaides KH
    BJOG; 2023 Apr; 130(5):524-530. PubMed ID: 36562190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis.
    Waugh J; Hooper R; Lamb E; Robson S; Shennan A; Milne F; Price C; Thangaratinam S; Berdunov V; Bingham J
    Health Technol Assess; 2017 Oct; 21(61):1-90. PubMed ID: 29064366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study.
    Beardmore-Gray A; Vousden N; Silverio SA; Charantimath U; Katageri G; Bellad M; Chinkoyo S; Vwalika B; Goudar S; Sandall J; Chappell LC; Shennan AH
    Reprod Health; 2021 Jun; 18(1):110. PubMed ID: 34078408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis.
    von Dadelszen P; Bhutta ZA; Sharma S; Bone J; Singer J; Wong H; Bellad MB; Goudar SS; Lee T; Li J; Mallapur AA; Munguambe K; Payne BA; Qureshi RN; Sacoor C; Sevene E; Vidler M; Magee LA;
    Lancet; 2020 Aug; 396(10250):553-563. PubMed ID: 32828187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WHO antenatal care randomised controlled trial: rationale and study design.
    Villar J; Bakketeig L; Donner A; al-Mazrou Y; Ba'aqeel H; Belizán JM; Carroli G; Farnot U; Lumbiganon P; Piaggio G; Berendes H
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():27-58. PubMed ID: 9805722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.